Vascular Intervention: BIOTRONIK Portfolio Expanded with Fortress Introducer Sheath for Peripheral Interventions
In Response to the Success of its 4F Introducer Sheath, BIOTRONIK Has Expanded its Line to Include 5F and 6F
"Essential functions of a sheath introducer are to allow me the flexibility to maneuver through complex vascular anatomy, while maintaining stability to prevent any complications inserting and removing balloon catheters and stents," said Flavio Airoldi, MD, MultiMedica Hospital, Milan, Italy.
The Fortress Introducer Sheaths are reinforced with a resilient and flexible stainless steel coil which provides a maximum degree of flexibility and stability to introduce a balloon catheter or self-expanding stent to treat diseased arteries. The coil simultaneously provides reinforcement to prevent kinks that can occur in the shaft during such procedures.
The 5F and 6F versions of the Fortress also retain a lubricious hydrophobic coating and smooth tapered tip design, making them easier to insert, and have been demonstrated to limit potential complications at the injection site.
"Rigorous internal benchmark testing has revealed the Fortress Introducer Sheath offers as best in class insertion performance, along with unparalleled kink resistance and stability," said Dr. Alexander Uhl, Vice President Marketing Vascular Intervention at BIOTRONIK. "We pride ourselves on providing physicians with a broad array of solutions for each patient, and the new 5F and 6F options are vital additions to our growing portfolio of VI solutions, which includes our trusted peripheral portfolio of Passeo balloons and Pulsar stents."
The new Fortress series is now available in CE accepting countries.
One of the world's leading manufacturers of cardio- and endovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries by its global workforce of more than 5800 employees. Several million patients have received BIOTRONIK implants designed to save and improve the quality of their lives, or have been treated with BIOTRONIK coronary and peripheral vascular intervention products. Since its development of the first German pacemaker in 1963, BIOTRONIK has engineered many innovations, including BIOTRONIK Home Monitoring®; the world's first 4 F-compatible 200mm peripheral stent; Orsiro, the industry's first hybrid drug-eluting stent; and the world's first implantable cardioverter-defibrillators and heart failure therapy devices with ProMRI® technology.
For more information, visit: www.biotronik.com